Elisa Rossi
University of Modena and Reggio Emilia · 182 works · 10,377 citations · h-index 35
Top works
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer
- Massive Pulmonary Embolism
- Right heart thrombi in pulmonary embolism
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
- Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer
- IncreasedHER2Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients
- Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC
- Prognostic Role of Echocardiography Among Patients With Acute Pulmonary Embolism and a Systolic Arterial Pressure of 90 mm Hg or Higher
- Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
- Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy
- PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
- Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial
- EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
- MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
- Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
- The Real-World Evidence of Heart Failure: Findings from 41 413 Patients of the ARNO Database
- Drug utilisation profile in the Italian paediatric population
- HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
- EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)
- A Standards-Based Architecture Proposal for Integrating Patient mHealth Apps to Electronic Health Record Systems